POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER: Pharmaceutical manufacturers, suppliers, and distributors

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
B Braun	POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	potassium chloride; sodium chloride	INJECTABLE;INJECTION	019708	NDA	B. Braun Medical Inc.	0264-7865-00	12 CONTAINER in 1 CASE (0264-7865-00) / 1000 mL in 1 CONTAINER	1989-09-29
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: July 30, 2025

Introduction

Potassium Chloride (KCl) solutions diluted in Sodium Chloride (NaCl) serve as vital intravenous (IV) therapy components used to treat electrolyte imbalances, prevent hypokalemia, and support cardiac and muscular function. The formulation of Potassium Chloride 0.037% in Sodium Chloride 0.9%, packaged in plastic containers, represents a standard isotonic IV solution known as "potassium chloride infusion." As demand for electrolyte replacement therapies escalates globally, sourcing high-quality, reliable suppliers becomes crucial for pharmaceutical companies, healthcare providers, and distributors.

This report analyzes leading manufacturers, authorized suppliers, and contract manufacturing organizations (CMOs) specializing in this formulation, with attention to regulatory compliance, production capacity, and geographical reach.

Market Overview and Significance

The global IV fluids market was valued at approximately USD 9 billion in 2020, with electrolyte solutions comprising a significant segment due to their essential therapeutic role [1]. Among these, potassium chloride solutions hold prominent importance, especially for correcting hypokalemia and supporting cardiac functions. The specific formulation—Potassium Chloride 0.037% in 0.9% Sodium Chloride—is designed for controlled electrolyte replenishment, making its quality and supply chain critical.

The manufacturing of such specialized solutions necessitates adherence to Good Manufacturing Practices (GMP), extensive quality controls, and compliance with international pharmacopoeias like USP, EP, or JP.

Key Suppliers and Manufacturers

1. Baxter International Inc.

Overview: A global leader in IV solutions and hospital products, Baxter produces multiple electrolyte IV formulations, including potassium chloride in sodium chloride. Their extensive manufacturing network guarantees high-quality standards and global distribution.

Product Range: Baxter's "Hartmann's Solution" and "Sterofund" series include potassium chloride infusion solutions in flexible plastic containers.

Regulatory Status: Baxter's products are FDA-approved, CE-marked, and compliant with global standards, ensuring broad international market access.

Supply Capabilities: Baxter’s manufacturing facilities in the United States, UK, and globally hold large capacities, ensuring consistent supply.

2. B. Braun Melsungen AG

Overview: B. Braun specializes in IV therapy solutions, offering a range of electrolyte infusions, including potassium chloride in sodium chloride solutions.

Product Range: Their products like "Intrapur" and "Sterofund" are packaged in polyvinyl chloride (PVC) or alternative plastic containers, compliant with industry standards.

Regulatory Status: B. Braun's products are widely approved, with a significant footprint in Europe, North America, and Asia.

Supply Capabilities: Their extensive production facilities ensure reliable supply chains to meet global demand.

3. ICU Medical (Prev. Hospira/Purdue Pharma)

Overview: ICU Medical is recognized for manufacturing sterile IV solutions, including potassium chloride in saline solutions.

Product Range: Includes pre-packaged IV fluids in plastic containers, with a focus on safety and stability.

Regulatory Status: Approved by the FDA and other regulatory agencies, ICU Medical maintains GMP standards.

4. Fresenius Kabi AG

Overview: A major player in infusion therapies, Fresenius offers electrolyte solutions, including potassium chloride in sodium chloride. Their range caters to multiple markets.

Product Range: "Fresenius Isoflur" series contains potassium chloride solutions.

Regulatory Status: Their products meet the stringent standards of the US, EU, and other markets, with extensive manufacturing facilities.

5. Local and Regional Suppliers

Numerous regional manufacturers in India, China, and Eastern Europe produce generic potassium chloride saline solutions. While offering cost advantages, detailed assessment of quality, GMP compliance, and regulatory approval is crucial before procurement.

Regulatory Considerations and Compliance

The procurement of pharmaceutical-grade IV solutions demands strict adherence to regulatory standards:

United States: FDA approval, CGMP compliance, and registration with the Drug Enforcement Administration (DEA) for controlled substances.
European Union: CE marking, compliance with EudraLex, and EMA approval.
Asia-Pacific: Compliance with local regulatory agencies such as the CFDA (China), TGA (Australia), and PMDA (Japan).

Manufacturers must supply certificates of analysis (CoA), stability data, and Good Manufacturing Practice (GMP) certificates.

Procurement and Supply Chain Dynamics

Reliability hinges on the ability to maintain uninterrupted supply chains, especially amid global disruptions COVID-19 underscored. Key factors include:

Production Capacity: Top-tier manufacturers maintain high throughput and contingency plans.
Lead Times: Orders typically require 4-12 weeks, depending on supplier and country.
Pricing Factors: Cost is influenced by raw material availability, manufacturing complexity, and regulatory compliance.
Logistics: Cold chain management is not critical for potassium chloride saline solutions but maintaining sterility and integrity remains essential.

Emerging Suppliers and Contract Manufacturing Options

For organizations seeking OEM/ODM partnerships, several contract manufacturing organizations (CMOs) offer customization, quality assurance, and specialized packaging in plastic containers for this formulation:

Recipharm (Sweden) – Offers sterile manufacturing of electrolyte infusions.
Nipro Corporation (Japan) – Specializes in sterile solution production.
Famar (Greece) – Provides contract manufacturing for IV solutions.

Engaging with CMOs provides flexibility in supply volume, formulation adjustments, and packaging configurations.

Quality Assurance and Validation

Ensuring pharmaceutical quality involves:

Validating sterility, pyrogenicity, and stability.
Verifying raw material quality, especially potassium chloride and sodium chloride.
Conducting in-process controls during manufacturing.
Maintaining cold chain and storage standards.

Suppliers should provide batch-specific Certificates of Analysis and stability data conforming to pharmacopeial standards.

Summary of Leading Suppliers

Supplier	Region	Key Products	Regulatory Certifications	Notes
Baxter International	Global	Potassium Chloride in Sodium Chloride Solutions	FDA, CE, WHO-GMP	Extensive capacity, wide distribution
B. Braun	Europe, NA	Electrolyte IVs in plastic containers	CE, US FDA	Focus on safety and compliance
ICU Medical	Global	IV solutions, including potassium chloride	FDA, CE	Innovative safety features
Fresenius Kabi	Global	Electrolyte infusions	EMA, US FDA	Large manufacturing network
Recipharm	Europe	Contract manufacturing	GMP, ISO	Custom formulations and packaging

Key Takeaways

Leading global manufacturers like Baxter, B. Braun, Fresenius Kabi, and ICU Medical dominate the supply of potassium chloride in sodium chloride infusions in plastic containers.
Regulatory compliance is non-negotiable; ensure suppliers possess necessary certifications and documentation.
Regional suppliers can offer cost advantages but require rigorous quality verification and compliance checks.
Contract manufacturing organizations present flexible options for OEM production, especially for customized formulations or packaging.
Supply chain resilience necessitates partnerships with multiple suppliers and contingency planning, especially amid global disruptions.

FAQs

1. What are the primary considerations when sourcing potassium chloride 0.037% in saline solutions?
Regulatory approval, GMP compliance, raw material quality, certified documentation, and a supplier’s manufacturing capacity are critical considerations.

2. Which regions host the most reliable manufacturing sources for this formulation?
North America (USA), Europe (Germany, France), and Asia (India, China) host reputable manufacturers with robust quality standards.

3. How do I verify the quality of a potential supplier?
Request Certificates of Analysis, GMP certification, manufacturing audit reports, and ensure compliance with pharmacopeial standards.

4. What logistical factors impact procurement of this IV solution?
Lead times, cold chain requirements, transportation modes, customs clearance, and regional distribution networks influence supply reliability.

5. Are there emerging markets or suppliers for these solutions?
Yes, regional manufacturers in Asia and Eastern Europe are expanding; however, due diligence is essential for quality assurance and regulatory compliance.

References

[1] MarketsandMarkets. IV Solutions Market by Type, Application, and Region - Global Forecast to 2025.
[2] IQVIA. The Global Use of IV Solutions and Electrolytes, 2022.
[3] US Food & Drug Administration. Drug Approvals and GMP Compliance Reports.
[4] European Medicines Agency. Regulatory Standards for IV Solutions.

Suppliers and packagers for POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER